Enhanced phytoextraction of cadmium and zinc using rapeseed

In a green house pot experiment, the effects of three amendments, sulphur (S), ammonium sulphate ((NH4)(2)SO4) and ethylenediaminetetracetic acid (EDTA) were tested for phytoextraction of Cd and Zn by rapeseed (Brassica napus L.). Elemental sulphur was applied as 20.00, 60.00, and 120.00 mg.kg(-1) soil. EDTA was tested at a dose of 585.00 mg.kg(-1) soil, and (NH4)(2)SO4) at a rate of 0.23 mg.kg(-1) soil. All treatments received a base fertilization (Hogland) before sowing. Plants were harvested after 51 days of growth and shoot dry matter and soil samples were analysed for metal contents. All amendments caused a significant increase in Cd and Zn contents in plant shoots of all treatments than control treatment. Further, EDTA was most effective for extraction metals concentrations in shoot biomass but the plants showed significant signs of toxicity and yield were severely depressed. The addition of sulfur favorably influenced plant biomass production. The fertilized ammonium sulfate treatment resulted in the highest phytoextraction of Cd and Zn and the amounts of these metals accumulated in plant shoot exceeded by a factor of 4 and 3 respectively. Finally, Brassica napus could be used for soil remediation keeping its other uses which will make the contaminated site income generating source for the farmers

Famciclovir for ophthalmic zoster: a randomised aciclovir controlled study

AIMS—To compare the efficacy and safety of famciclovir with aciclovir for the treatment of ophthalmic zoster.
METHODS—Randomised, double masked, aciclovir controlled, parallel group in 87 centres worldwide including 454 patients with ophthalmic zoster of trigeminal nerve (V(1)) comprised the intent to treat population. Oral famciclovir 500 mg three times daily or oral aciclovir 800 mg five times daily for 7 days. Assessments included day 0 (screening), days 3 and 7 (during treatment), days 10, 14,( )21, 28 and monthly thereafter, up to 6 months (follow up). Proportion of patients who experienced ocular manifestations, severe manifestations and non-severe manifestations; loss of visual acuity was the main outcome measure.
RESULTS—The percentage of patients who experienced one or more ocular manifestations was similar for famciclovir (142/245, 58.0%) and aciclovir (114/196, 58.2%) recipients, with no significant difference between groups (OR 0.99; 95% CI 0.68, 1.45). The percentage of patients who experienced severe and non-severe manifestations was similar between groups, with no significant difference. The prevalence of individual ocular manifestations was comparable between groups. There was no significant difference between groups for visual acuity loss.
CONCLUSION—Famciclovir 500 mg three times daily was well tolerated and demonstrated efficacy similar to aciclovir 800 mg five times daily.


Populus nigra network. Report

International audienc